Anxiolytic Effects of Socio-aesthetics in Cancer Patients Undergoing Chemotherapy

Launched by GCS RAMSAY SANTÉ POUR L'ENSEIGNEMENT ET LA RECHERCHE · Dec 5, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at how socio-aesthetics, which includes beauty and wellness treatments, can help reduce anxiety in cancer patients who are receiving chemotherapy. The researchers want to compare the anxiety levels of participants before starting their treatment and after they have completed three cycles of chemotherapy. By doing this, they aim to see if these supportive therapies can make a difference in how patients feel during a challenging time.

To be eligible for this study, participants must be cancer patients who are starting their first round of chemotherapy and will be receiving it every two to three weeks. They should be able to understand and speak French and complete questionnaires about their feelings. However, those who have already received similar beauty or wellness treatments, or who have certain legal or health conditions, will not be able to participate. If you join the trial, you can expect to fill out surveys about your anxiety levels at different points during your treatment, helping researchers understand the potential benefits of socio-aesthetic care for patients undergoing chemotherapy.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient with cancer treated with adjuvant chemotherapy with an interval of 14 or 21 days for the first 3 cycles;
• • Chemotherapy naïve patient;
• • Patient speaking and understanding French and able to complete the questionnaires;
• • Patient having been informed and having signed an informed consent form to participate in the study.
• Exclusion Criteria:
• • Patient who has already benefited from socio-aesthetic care;
• • Protected patient (under legal protection, or deprived of liberty by judicial or administrative decision);
• • Patient unable to understand the information related to the study (linguistic, psychological, cognitive reasons, etc.);
• • Pregnant or likely to be pregnant (of childbearing age, without effective contraception) or breastfeeding;
• • Patient participating in another clinical trial, or in a period of exclusion from another clinical trial;
• • Patient not benefiting from a social security scheme.